NeuImmune

Q: What is NeuImmune's official website?

NeuImmune's official website is www.neuimmune.com

Q: What is NeuImmune's Revenue?

NeuImmune's revenue is <$5 Million

Q: What industry does NeuImmune belong to?

NeuImmune is in the industry of: Business Services , Research & Development

Q: Who is the CTO of NeuImmune?

NeuImmune's CTO is Nathan Lewis

Q: How do I contact NeuImmune?

NeuImmune contact info: Phone number: (301) 861-0009 Website: www.neuimmune.com

Q: What does NeuImmune do?

NeuImmune, Inc. is an early-stage biotechnology company specializing in glyco- and cell-engineering, founded by leading scientists from prestigious universities. The company aims to become a leader in glycoprotein therapeutics, focusing on enzyme replacement therapies for orphan diseases, particularly lysosomal storage disorders. NeuImmune has deve... loped innovative technologies, including the geCHO BioDesign Platform and ICAM-1 Targeting Technology, to enhance the production and delivery of therapeutic proteins. Their target clients include patients with unmet medical needs in the realm of rare diseases. Read More

Q: Is NeuImmune a public company?

NeuImmune is private company therefore does not currently have an official ticker symbol

Business Services · Maryland, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

1500 Fannie Dorsey Rd, Sykesville, Maryl...

Phone Number

(301) 861-0009

Website

www.neuimmune.com

Revenue

<$5 Million

Industry

Business Services

Research & Development

ZI Rank: 1

Signal Type

Mar

Apr

May

Jun

Jul

Aug

ZI Rank

About NeuImmune

NeuImmune, Inc. is an early-stage biotechnology company specializing in glyco- and cell-engineering, founded by leading scientists from prestigious universities. The company aims to become a leader in glycoprotein therapeutics, focusing on enzyme replacement therapies for orphan diseases, particularly lysosomal storage disorders. NeuImmune has developed innovative technologies, including the geCHO BioDesign Platform and ICAM-1 Targeting Technology, to enhance the production and delivery of therapeutic proteins. Their target clients include patients with unmet medical needs in the realm of rare diseases.Explore more

Is this data correct?

View contact profiles from NeuImmune

Popular SearchesNeuimmune IncSIC Code 87,873NAICS Code 54,541Show more

NeuImmune Org Chart

Phone

Nathan Lewis

Chief Technology Officer

Phone

Get the full picture

Is NeuImmune your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Last 7 days

Check if NeuImmune has recently received funding, and reach out quickly before it becomes old news!

Click to see if NeuImmune had a recent Job posting/layoffs

Earning: See what the market has to say on NeuImmune recently announced quarterly report

Funding: Get notified immidiatlly once NeuImmune has new funding data

Product Launch: Get notified when NeuImmune launches new products

Website visits: Recent activity has been detected on your website

Congratulate Masked Content for being promoted to Masked Content at NeuImmune

NeuImmune, which may be a good buyer, showed buying intent in Masked Content Topic

Competitive Alert! Recent activity has been detected by your competitor Masked Content

Check out if NeuImmune is spiking on competitors!

Recommended Actions

Find VP level buyers at NeuImmune

Find 2 more new buyers

View Email Formats for NeuImmune

Among all Business Services companies

Low Activity

High Activity

Activity Insights

NeuImmune is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

NeuImmune is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about NeuImmune.